Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Okeechobee › NPI 1215974134
Hospital

Okeechobee Hospital, INC.

Okeechobee Hospital, INC. was paid $14.85M by Medicaid between Jan 2018 and Dec 2024, across 161 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoOKEECHOBEE HOSPITAL, INC.
OKEECHOBEE, FL 34972
33aNPI1215974134assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.85M
24GClaims419,391
24DCodes billed161
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#31 of 163
Median peer was paid$4.77M
This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201834,780$394K
201978,717$2.55M
202069,662$1.80M
202176,204$2.53M
202274,588$3.27M
202354,202$2.60M
2024incomplete31,238$1.71M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 23% 27,990 25,539 $3.39M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 18,336 15,713 $1.80M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 11% 11,760 2,548 $1.69M
97530 Therapeutic activities, direct patient contact, each 15 minutes 10% 13,453 3,072 $1.54M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 7.8% 9,310 2,473 $1.16M
74176 Computed tomography, abdomen and pelvis; without contrast material 5.7% 3,541 3,107 $844K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.5% 5,079 4,795 $671K
70450 Computed tomography, head or brain; without contrast material 2.8% 3,721 3,126 $420K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.8% 4,236 3,336 $268K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 1,376 1,225 $248K
80053 Comprehensive metabolic panel 1.6% 17,027 13,393 $240K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.5% 1,386 1,295 $217K
149 more codes
96361 Intravenous infusion, hydration; each additional hour 1.3% 1,611 $200K
80048 Basic metabolic panel (calcium, ionized) <1% 9,139 $117K
87070 <1% 7,333 $95K
72125 Computed tomography, cervical spine; without contrast material <1% 1,178 $93K
97163 <1% 609 $88K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,114 $82K
A9270 Non-covered item or service <1% 9,628 $74K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 493 $71K
36415 Collection of venous blood by venipuncture <1% 3,178 $70K
85027 <1% 26,504 $66K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,056 $59K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,531 $57K
73610 <1% 689 $56K
G0378 Hospital observation service, per hour <1% 3,206 $52K
71275 Computed tomographic angiography, chest, with contrast material <1% 119 $48K
81001 <1% 9,814 $47K
84484 <1% 8,086 $46K
71045 Radiologic examination, chest; single view <1% 11,968 $44K
81025 <1% 6,535 $43K
71046 Radiologic examination, chest; 2 views <1% 2,511 $40K
73030 <1% 771 $38K
J3490 Unclassified drugs <1% 563 $36K
73564 <1% 872 $34K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,844 $33K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 279 $31K
87040 <1% 4,195 $30K
81003 <1% 4,266 $30K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13,210 $28K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,764 $27K
80076 <1% 2,952 $23K
87275 <1% 9,601 $22K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,721 $22K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,298 $22K
J7050 Infusion, normal saline solution, 250 cc <1% 2,224 $21K
73130 <1% 629 $21K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,494 $20K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 922 $20K
73110 <1% 540 $19K
92523 <1% 111 $19K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,303 $19K
77067 Screening mammography, bilateral, including computer-aided detection <1% 840 $19K
73630 <1% 728 $19K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 192 $17K
87088 <1% 2,458 $16K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 258 $16K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 6,044 $15K
77063 Screening digital breast tomosynthesis, bilateral <1% 660 $14K
85610 <1% 9,276 $12K
80047 <1% 1,057 $12K
74018 <1% 621 $12K
83735 <1% 7,891 $11K
85730 <1% 5,979 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,507 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 6,089 $9K
74019 <1% 254 $9K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 61 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,583 $9K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,385 $9K
76830 Ultrasound, transvaginal <1% 163 $9K
73502 <1% 215 $8K
J2704 Injection, propofol, 10 mg <1% 329 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 7,351 $8K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 53 $7K
82565 <1% 99 $7K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 585 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,177 $6K
84702 <1% 686 $6K
97162 <1% 32 $5K
85014 <1% 18 $5K
83605 <1% 3,308 $5K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 30 $5K
93971 <1% 62 $4K
83690 <1% 6,919 $4K
72131 <1% 74 $4K
72110 <1% 79 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 850 $4K
87807 <1% 3,263 $4K
83880 <1% 2,268 $3K
82248 <1% 1,700 $3K
71250 <1% 59 $3K
87276 <1% 9,597 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,146 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,093 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 618 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,343 $3K
76536 <1% 28 $3K
82805 <1% 314 $2K
97167 <1% 27 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 519 $2K
86900 <1% 618 $2K
76641 <1% 16 $1K
85379 <1% 1,534 $1K
73620 <1% 12 $1K
84443 Thyroid stimulating hormone (TSH) <1% 1,750 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 754 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 129 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 927 $1K
80061 Lipid panel <1% 1,390 $1K
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 104 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 811 $936.55
83036 Hemoglobin; glycosylated (A1C) <1% 1,157 $869.48
82247 <1% 318 $863.03
82040 <1% 317 $840.17
84075 <1% 297 $837.62
84450 <1% 297 $837.62
84460 <1% 296 $837.62
84155 <1% 296 $831.75
86901 <1% 617 $670.82
J1815 Injection, insulin, per 5 units <1% 646 $659.26
70551 Magnetic resonance imaging, brain; without contrast material <1% 14 $649.34
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 17 $644.38
82607 <1% 514 $642.10
73562 <1% 44 $495.43
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 38 $429.81
88342 <1% 14 $403.02
J2550 Injection, promethazine hcl, up to 50 mg <1% 471 $401.59
82150 <1% 129 $396.99
82077 <1% 395 $373.11
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 334 $329.95
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 22 $324.86
85651 <1% 497 $301.19
84520 <1% 50 $249.69
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 487 $232.46
86140 <1% 331 $230.44
J2060 Injection, lorazepam, 2 mg <1% 266 $228.47
85018 <1% 18 $214.47
36600 <1% 295 $208.14
84703 <1% 64 $208.00
82550 <1% 652 $204.88
96376 <1% 210 $202.57
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 21 $192.29
84439 <1% 263 $142.10
76801 <1% 16 $126.70
82728 <1% 137 $125.76
86850 <1% 62 $13.02
80320 0% 207 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 27 $0.00
84436 0% 14 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 54 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 55 $0.00
84134 0% 14 $0.00
82553 0% 18 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 1,022 $0.00
S0028 Injection, famotidine, 20 mg 0% 222 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 57 $0.00
J7510 Prednisolone oral, per 5 mg 0% 45 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 12 $0.00
84100 0% 21 $0.00
87186 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJACOBSON, JOHN (CFO)